ATE209187T1 - Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen - Google Patents

Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen

Info

Publication number
ATE209187T1
ATE209187T1 AT95927535T AT95927535T ATE209187T1 AT E209187 T1 ATE209187 T1 AT E209187T1 AT 95927535 T AT95927535 T AT 95927535T AT 95927535 T AT95927535 T AT 95927535T AT E209187 T1 ATE209187 T1 AT E209187T1
Authority
AT
Austria
Prior art keywords
tumor cells
hypoxic tumor
nitroimidazole
fluorinated
analogue
Prior art date
Application number
AT95927535T
Other languages
English (en)
Inventor
Michael Tracy
Andrew B Kelson
Paul Workman
Alexander D Lewis
Eric O Aboagye
Original Assignee
Stanford Res Inst Int
Univ Glasgow
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int, Univ Glasgow, Cancer Res Campaign Tech filed Critical Stanford Res Inst Int
Application granted granted Critical
Publication of ATE209187T1 publication Critical patent/ATE209187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95927535T 1994-08-05 1995-07-31 Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen ATE209187T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28647794A 1994-08-05 1994-08-05
US08/458,178 US5721265A (en) 1994-08-05 1995-06-02 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
PCT/US1995/009611 WO1996004249A1 (en) 1994-08-05 1995-07-31 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells

Publications (1)

Publication Number Publication Date
ATE209187T1 true ATE209187T1 (de) 2001-12-15

Family

ID=26963851

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927535T ATE209187T1 (de) 1994-08-05 1995-07-31 Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen

Country Status (10)

Country Link
US (1) US5721265A (de)
EP (1) EP0775117B1 (de)
JP (1) JP3872511B2 (de)
AT (1) ATE209187T1 (de)
CA (1) CA2196900C (de)
DE (1) DE69524103T2 (de)
DK (1) DK0775117T3 (de)
ES (1) ES2165430T3 (de)
PT (1) PT775117E (de)
WO (1) WO1996004249A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US6252087B1 (en) * 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US20050026974A1 (en) * 1996-02-08 2005-02-03 Trustees Of The University Of Pennsylvania Detection of hypoxia
ES2123449B1 (es) * 1997-03-06 1999-09-16 Univ Madrid Nac Educacion Procedimiento para la obtencion de imagenes y espectros del ph extracelular por resonancia magnetica con indicadores extrinsecos conteniendo 1h o 19f.
EP1009753B1 (de) * 1997-08-21 2005-04-20 Quark Biotech, Inc. Hypoxie-regulierte gene
JP2002525350A (ja) * 1998-09-25 2002-08-13 モンサント カンパニー コレステロールエステル輸送タンパク質活性阻害に有効な置換されたｎ−脂肪族−ｎ−芳香族第三級ヘテロアルキルアミン
US7230115B1 (en) 1999-07-21 2007-06-12 The Trustees Of The University Of Pennsylvania Preparation of compounds useful for the detection of hypoxia
WO2001007414A1 (en) * 1999-07-21 2001-02-01 The Trustees Of The University Of Pennsylvania Preparation of compounds useful for the detection of hypoxia
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
AU2001233996A1 (en) * 2000-02-14 2001-08-20 Novolytic, Inc. Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
DE102005063244A1 (de) * 2005-12-21 2007-06-28 Eberhard-Karls-Universität Tübingen Modifiziertes 2-Nitroimidazol-Derivat
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
US7807394B2 (en) 2007-04-05 2010-10-05 Siemens Medical Solutions Usa, Inc. Nitro-imidazole hypoxia imaging agents
EP2123620A1 (de) * 2008-05-20 2009-11-25 Bayer Schering Pharma Aktiengesellschaft {F-19}-markierte L-Glutaminsäure und L-Glutaminderivat (III), Verwendung davon und Verfahren zu deren Erhalt
WO2010073126A2 (en) * 2008-12-22 2010-07-01 The Governors Of The University Of Alberta Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
CN101624392B (zh) * 2009-08-10 2014-07-09 北京师范大学 F-三唑环-聚乙二醇-2-硝基咪唑化合物及其制备方法
US9074129B2 (en) 2009-12-01 2015-07-07 University Of Virginia Patent Foundation Mechanochromic luminescent difluoroboron beta-diketonates
CN113501789B (zh) * 2021-06-16 2023-03-31 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 一种硝基咪唑类衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505349A (en) * 1966-04-18 1970-04-07 Hoffmann La Roche 2-nitro-imidazolyl-1-acetamides
US5304654A (en) * 1987-06-10 1994-04-19 Yasunori Nishijima Fluorine-containing nitroimidazole compounds
CA1329206C (en) * 1987-06-10 1994-05-03 Tsutomu Kagiya Fluorine-containing nitroazole derivatives and radiosensitizer comprising the same
IL92597A0 (en) * 1988-12-14 1990-08-31 Yasunori Nishijima President K Novel fluorine-containing 2-nitroimidazole derivatives and radiosensitizer comprising the same
EP0669913B1 (de) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Nachweis von hypoxia

Also Published As

Publication number Publication date
JP3872511B2 (ja) 2007-01-24
CA2196900C (en) 2009-02-24
DK0775117T3 (da) 2002-05-21
US5721265A (en) 1998-02-24
DE69524103D1 (de) 2002-01-03
JPH10506104A (ja) 1998-06-16
PT775117E (pt) 2002-05-31
ES2165430T3 (es) 2002-03-16
WO1996004249A1 (en) 1996-02-15
DE69524103T2 (de) 2002-07-18
EP0775117A1 (de) 1997-05-28
CA2196900A1 (en) 1996-02-15
EP0775117B1 (de) 2001-11-21

Similar Documents

Publication Publication Date Title
ATE209187T1 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
SE7906533L (sv) Pyrrolidinderivat
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
ES551531A0 (es) Procedimiento para detectar peroxido de hidrogeno o sustancias formadoras de peroxido de hidrogeno
ATE301122T1 (de) Kernerweiterte perylenbisimide und ihre verwendung als fluoreszenzfarbstoffe
NO904114D0 (no) Pyrimidon-4,6-dikarboksylsyrediamider samt fremgangsmaate for fremstilling derav.
ATE249440T1 (de) Flüssige benzisochinoline derivate
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
SE8207302L (sv) Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma
ATE30719T1 (de) Imino-2-pyrrolidine, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
EA199900754A1 (ru) Способ получения замещенного тиазолидиндиона
DK0871612T3 (da) Kondenserede isoindoloner som proteinkinase C-inhibitorer
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика
ATE153657T1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
DK0426557T3 (da) Fremgangsmåde til fremstilling af (1R,2R)-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamid-1-oxider, mellemprodukter anvendt ved denne fremgangsmåde og fremstilling af disse mellemprodukter
ES2043784T3 (es) Procedimiento de preparacion de compuestos guanidinicos.
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
ES517874A0 (es) Procedimiento de preparacion de derivados de diaza-3,7a-cicloherta-(j,k)-fluorenos.
DK0555283T3 (da) Mellemprodukter ved fremstillingen af 4,5-difluoranthranilinsyre
ATE85604T1 (de) Verfahren zur herstellung von 4-bromanilinhydrobromiden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee